To date, it appears that pain, inflammation, and cancer are associated with IKKε- or TBK1-specific NF-κB pathway activation while IRFs and the IFN pathways are involved in pathologies such as rheumatic diseases [7]. This evidence concerns the gene TBK1 and cancer.